EUVIMEDEUVIMED entdecken
Crossref

The effects of alfaxalone on cardiac and pulmonary vascular size in cats evaluated by thoracic radiography and echocardiography

Michael Schettler iD, Merrilee Holland iD, Erik Hofmeister, Randolph Winter

Veterinary Radiology & Ultrasound · 2024

DOI: 10.1111/vru.13423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Radiology & Ultrasound, 2024. Verfasst von Michael Schettler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Auburn University College of Veterinary Medicine Auburn, Auburn, Alabama, USA. Hauptthemen laut MEDLINE: Pregnanediones, Echocardiography, Radiography, Thoracic. Die Arbeit nennt 24 Literaturangaben. Gefördert von: American College of Veterinary Radiology's Resident Research Grant Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alfaxalone is a neuroactive steroid that modulates the GABA A receptor, which has shown recent widespread use as a sedative and anesthetic agent in cats, especially in patients being screened for cardiovascular disease. This prospective, partially blinded, randomized experimental study aimed to determine if sedation with alfaxalone would alter the appearance of the cardiac silhouette or pulmonary vasculature on thoracic radiographs or echocardiographic indices of cardiac or pulmonary vascular size. Eleven apparently healthy adult cats were recruited from a research colony. Four‐view thoracic radiographs and an echocardiogram were performed at baseline and following a 5 mg/kg intramuscular dose of alfaxalone. Vertebral heart score (VHS) and cranial and caudal lobar pulmonary vascular measurements were obtained at both time points by two independent blinded observers, and these were analyzed using two‐way ANOVA. The nonblinded echocardiographer obtained echocardiographic measurements at both time points, which were analyzed using a paired t ‐test or Wilcoxon signed rank test. No significant differences were identified in VHS measurements or echocardiographic parameters between baseline and sedated cats. In healthy cats, alfaxalone does not appear to significantly affect the cardiovascular structures evaluated via thoracic radiography or echocardiography.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregnanedionesEchocardiographyRadiography, ThoracicAnimalsCatsMaleFemaleProspective StudiesHeartAnestheticsLung

Stichwörter der Autor:innen

cardiomegalyscreeningvertebral heart score

Substanzen

alphaxalonePregnanedionesAnesthetics

Autor:innen und Institutionen

  • Department of Clinical Sciences, Auburn University College of Veterinary Medicine Auburn, Auburn, Alabama, USA.

ORCID-Profile: Michael Schettler, Merrilee Holland

Förderung

  • American College of Veterinary Radiology's Resident Research Grant Award

Zitieren

APA

Schettler, M., Holland, M., Hofmeister, E., & Winter, R. (2024). The effects of alfaxalone on cardiac and pulmonary vascular size in cats evaluated by thoracic radiography and echocardiography. Veterinary Radiology & Ultrasound. https://doi.org/10.1111/vru.13423

Vancouver

Schettler M, Holland M, Hofmeister E, Winter R. The effects of alfaxalone on cardiac and pulmonary vascular size in cats evaluated by thoracic radiography and echocardiography. Veterinary Radiology & Ultrasound. 2024. doi:10.1111/vru.13423

BibTeX
@article{Schettler2024,
  author = {Schettler, Michael and Holland, Merrilee and Hofmeister, Erik and Winter, Randolph},
  title = {The effects of alfaxalone on cardiac and pulmonary vascular size in cats evaluated by thoracic radiography and echocardiography},
  journal = {Veterinary Radiology & Ultrasound},
  year = {2024},
  doi = {10.1111/vru.13423}
}
Kostenlos starten →